Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The ENST00000349780.9(CDK5RAP2):c.880-7A>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00233 in 1,613,646 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
CDK5RAP2 (HGNC:18672): (CDK5 regulatory subunit associated protein 2) This gene encodes a regulator of CDK5 (cyclin-dependent kinase 5) activity. The protein encoded by this gene is localized to the centrosome and Golgi complex, interacts with CDK5R1 and pericentrin (PCNT), plays a role in centriole engagement and microtubule nucleation, and has been linked to primary microcephaly and Alzheimer's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 9-120527932-T-C is Benign according to our data. Variant chr9-120527932-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 158172.We mark this variant Likely_benign, oryginal submissions are: {Benign=3, Uncertain_significance=1}. Variant chr9-120527932-T-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0121 (1842/152310) while in subpopulation AFR AF= 0.0414 (1722/41570). AF 95% confidence interval is 0.0398. There are 43 homozygotes in gnomad4. There are 871 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitter
clinical testing
Genetic Services Laboratory, University of Chicago
Feb 08, 2013
- -
Primary Microcephaly, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitter